During the past decade, CHU Dijon - Hôpital d'Enfants conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Dijon - Hôpital d'Enfants" #1 sponsor was "The Lymphoma Academic Research Organisation" with 3 trials, followed by "Intergroupe Francophone du Myelome" with 2 trials sponsored, "Groupe Francophone des Myelodysplasies" with 1 trials sponsored, "Institut Curie" with 1 trials sponsored and "Jean Michel Hascoet" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Dijon - Hôpital d'Enfants" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "ARAIRLOR" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Celgene Corporation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "CHU Dijon - Hôpital d'Enfants" are "Multiple Myeloma" (4 trials), "Bronchopulmonary Dysplasia" (1 trials), "Central Nervous System Tumor" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Classical Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "CHU Dijon - Hôpital d'Enfants" in a lesser frequency.

Most popular intervention types in "CHU Dijon - Hôpital d'Enfants" are "Drug" (9 trials), "Other" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASCT" (1 trials), "Air" (1 trials), "Bendamustine" (1 trials), "Bortezomib (VELCADE), Thalidomide, and Dexamethasone (VTD)" (1 trials) and "Bortezomib, Thalidomide, Dexamethasone (VTD) + daratumumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Dijon - Hôpital d'Enfants" are 11 trials for "All" genders.

Currently, there are NaN active trials in "CHU Dijon - Hôpital d'Enfants". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in CHU Dijon - Hôpital d'Enfants, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CHU Dijon - Hôpital d'Enfants, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".